Page last updated: 2024-10-22

albuterol and Mast Cell Activation Disease

albuterol has been researched along with Mast Cell Activation Disease in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
"Patients with mastocytosis have an increased risk of anaphylaxis during surgical procedures with general anesthesia."3.01Perioperative management of mastocytosis. ( Butterfield, JH; Divekar, RD; Lau, S; Sprung, J; Volcheck, GW; Weingarten, TN, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lau, S1
Sprung, J1
Volcheck, GW1
Butterfield, JH1
Divekar, RD1
Weingarten, TN1

Reviews

1 review available for albuterol and Mast Cell Activation Disease

ArticleYear
Perioperative management of mastocytosis.
    Journal of anesthesia, 2023, Volume: 37, Issue:5

    Topics: Adult; Albuterol; Anaphylaxis; Anesthesia, General; Child; Humans; Mastocytosis; Retrospective Studi

2023